论文部分内容阅读
Objective: To assess the efficacy of Xianlong Capsule (XLC) in treating senile vascular dementia (VD). Methods: Forty six patients of VD were randomly divided into two groups. The patients in XLC group (n=24) were treated with XLC and the patients in the control group (n=22) were treated with Hydergine. The therapeutic effect on dementia, TCM Syndrome, neurofunction deficit score, activities of daily living (ADL) score, Hasegawa Dementia Score (HDS) and mini mental state examination (MMSE), etc. were examined and compared before and after treatment.Results: XLC could markedly increase MMSE scores and HDS of VD patients. It showed effect in ameliorating the TCM Syndromes and neurofunction deficit score significantly and could markedly improve the daily living activity of patients. The effect of XLC was better than that of Hydergine.Conclusion: XLC has definite effect in treating senile vascular dementia.
Objective: To assess the efficacy of Xianlong Capsule (XLC) in treating senile vascular dementia (VD). Methods: Forty six patients of VD were randomly divided into two groups. The patients in XLC group (n=24) were treated with XLC and The patients in the control group (n=22) were treated with Hydergine. The therapeutic effect on dementia, TCM Syndrome, neurofunction deficit score, activities of daily living (ADL) score, Hasegawa Dementia Score (HDS) and mini mental state examination ( MMSE), etc. were examined and compared before and after treatment.Results: XLC could markedly increased MMSE scores and HDS of VD patients. It showed effect in ameliorating the TCM Syndromes and neurofunction deficit score significantly and could markedly improve the daily living activity of Patients. The effect of XLC was better than that of Hydergine.Conclusion: XLC has definite effect in treating senile vascular dementia.